Phase 3 Long COVID Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
Taurine Supplementation in Long COVID
Long COVID
University of Alberta300 enrolled5 locationsNCT06721949
Recruiting
Phase 3
Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
Long Covid 19
Icahn School of Medicine at Mount Sinai80 enrolled1 locationNCT06960928
Recruiting
Phase 3
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
SARS-CoV-2 infectionCOVID-19Long COVID+1 more
Wes Ely550 enrolled17 locationsNCT06631287
Recruiting
Phase 2Phase 3
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Long COVIDSmell DysfunctionOlfactory Disorder
Medical University of South Carolina145 enrolled1 locationNCT05855369
Recruiting
Phase 3
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Long COVID
Douglas D. Fraser348 enrolled9 locationsNCT06928272
Recruiting
Phase 2Phase 3
Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome
Post-Acute COVID-19 SyndromeLong COVIDPost-Acute COVID-19
Hellenic Institute for the Study of Sepsis182 enrolled24 locationsNCT05926505